Foretinib demonstrates anti-tumor activity and improves overall survival in preclinical models of hepatocellular carcinoma.
about
The progress of angiogenic factors in the development of leukemiasRegulation of Bim in Health and DiseaseOckham's razor for the MET-driven invasive growth linking idiopathic pulmonary fibrosis and cancerForetinib Enhances the Radiosensitivity in Esophageal Squamous Cell Carcinoma by Inhibiting Phosphorylation of c-MetRON and c-Met facilitate metastasis through the ERK signaling pathway in prostate cancer cellsEstablishment of animal models with orthotopic hepatocellular carcinoma.Epidermal growth factor receptor pathway polymorphisms and the prognosis of hepatocellular carcinoma.Foretinib inhibits angiogenesis, lymphangiogenesis and tumor growth of pancreatic cancer in vivo by decreasing VEGFR-2/3 and TIE-2 signaling.Impact of MET targeting on tumor-associated angiogenesis and growth of MET mutations-driven models of liver cancer.Targeting the HGF/c-MET pathway in hepatocellular carcinoma.Differential Antitumoral Properties and Renal-Associated Tissue Damage Induced by Tacrolimus and Mammalian Target of Rapamycin Inhibitors in Hepatocarcinoma: In Vitro and In Vivo Studies.Genomic characterization of a large panel of patient-derived hepatocellular carcinoma xenograft tumor models for preclinical developmentc-Met inhibitors attenuate tumor growth of small cell hypercalcemic ovarian carcinoma (SCCOHT) populations.c-Met expression and activity in urogenital cancers - novel aspects of signal transduction and medical implications.Foretinib (XL880): c-MET inhibitor with activity in papillary renal cell cancer.Treating advanced hepatocellular carcinoma: How to get out of first gear.Advanced Hepatocellular Cancer: the Current State of Future Research.Tivantinib: a new promising mesenchymal-epithelial transition factor inhibitor in the treatment of hepatocellular carcinoma.Population pharmacokinetics modeling and analysis of foretinib in adult patients with advanced solid tumors.Dovitinib induces mitotic defects and activates the G2 DNA damage checkpoint.Clinical Development of c-MET Inhibition in Hepatocellular Carcinoma.Recent developments of c-Met as a therapeutic target in hepatocellular carcinoma.Gefitinib or lapatinib with foretinib synergistically induce a cytotoxic effect in melanoma cell lines.
P2860
Q26753835-C5585FE3-DAD8-4BD6-8F21-151D3A9E4795Q26781203-D4A074ED-2CE2-4F90-A143-F9D215E74783Q28067777-8BCA5F9C-A089-486A-B3C0-36FE10703711Q33702320-24868FDB-A1CC-43CA-A07B-F124830C8A66Q33721142-7BDBE789-1123-4446-B112-4149AD729191Q34090895-5469E22E-A56A-49FE-BBBD-601BD08CBBFEQ34991214-BCA102C5-BEA5-4B9D-82EE-53F19C8A03B4Q36020888-3A8F23DD-9115-492D-975B-A188B08288CAQ36075407-5C60F84C-27E9-4A65-8B19-5982CB83EC8EQ36093497-0E2CD50F-145E-48F3-AED8-0A356C36C1C0Q36102839-01CC6286-3A5E-4D16-9128-730519EA739BQ36299617-8A910D97-AEFD-4C4D-901B-3FAC997E0398Q36544653-151D1D43-B4E8-4C77-BF60-44DCBC27C80FQ37651008-E66B0D15-1C87-4C53-8186-83725047596EQ38081379-4CF462E0-0D1D-41ED-86F8-0178D5572AEBQ38217737-B2B9349E-B3A0-43BF-B29B-92AE27607FB9Q38848537-5D1C3ABA-AC69-4CB7-9BCB-373F9DEB299BQ39466467-21EE53C8-4C72-4935-9B2C-0258FDABEDFFQ40914650-9CE352C8-B7F6-45D4-A0B1-E7278040B1E6Q41923223-E9C8E69D-9F64-4956-AC65-20BF35F160C1Q42093061-F5A677A8-C03E-464C-9300-0544936CE386Q48140297-C7FA32D9-703A-465D-9761-E0D96F4912F0Q53688956-C5C64319-9D5B-4986-B9CE-8CA3C4EF61FC
P2860
Foretinib demonstrates anti-tumor activity and improves overall survival in preclinical models of hepatocellular carcinoma.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Foretinib demonstrates anti-tu ...... s of hepatocellular carcinoma.
@en
Foretinib demonstrates anti-tu ...... s of hepatocellular carcinoma.
@nl
type
label
Foretinib demonstrates anti-tu ...... s of hepatocellular carcinoma.
@en
Foretinib demonstrates anti-tu ...... s of hepatocellular carcinoma.
@nl
prefLabel
Foretinib demonstrates anti-tu ...... s of hepatocellular carcinoma.
@en
Foretinib demonstrates anti-tu ...... s of hepatocellular carcinoma.
@nl
P2860
P1433
P1476
Foretinib demonstrates anti-tu ...... ls of hepatocellular carcinoma
@en
P2093
Khee Chee Soo
Richard Ong
P2860
P2888
P356
10.1007/S10456-011-9243-Z
P50
P577
2011-12-21T00:00:00Z